Ortivus AB

Ortivus AB has a liquidity position that is marginally balanced, with a current ratio of 0.98, indicating that its current liabilities slightly exceed its current assets. The company's liquidity is further constrained by a negative net cash position after subtracting total debt, which is a key flag in its risk assessment. The company's cash and equivalents amount to 8,888,000 SEK, while its long-term debt stands at 19,527,000 SEK, resulting in a debt-to-equity ratio of 0.87. Profitability metrics for Ortivus are weak, with a return on equity (ROE) of -0.976 and a return on assets (ROA) of -0.3084, both significantly below the industry median for Advanced Medical Equipment & Technology firms. The company reported a net loss of 21,876,000 SEK and an operating loss of 19,805,000 SEK, reflecting poor operational performance. Gross profit of 29,600,000 SEK is insufficient to cover operating expenses, contributing to the negative net income. Geographically and segment-wise, Ortivus does not disclose detailed revenue concentration data in the provided financials. However, the company operates in a specialized segment of the healthcare industry, and its business model is likely concentrated in a few core product lines or geographic regions, as is typical for firms in the Advanced Medical Equipment & Technology industry. The company's growth trajectory is uncertain, with no specific outlook provided for the current or next fiscal year. Historical revenue of 73,401,000 SEK suggests a relatively small revenue base, and the negative operating and free cash flows indicate that the company is not generating sufficient cash to sustain operations without external financing. The capital expenditure of -9,593,000 SEK suggests ongoing investment in infrastructure or equipment, but this is being funded by negative cash flows rather than positive operating performance. Risk factors for Ortivus include its liquidity constraints and the potential for dilution, although the risk of dilution is currently assessed as low. The company's negative net cash position and operating cash flow of -25,238,000 SEK raise concerns about its ability to meet short-term obligations without additional financing. The risk assessment also highlights the need for close monitoring of the company's capital structure and cash flow generation. Recent events, including the latest financial filing (HA-latest), indicate that the company is in a challenging financial position. The operating and net losses, combined with negative cash flows, suggest that the company may need to secure additional financing or restructure its operations to improve its financial health.